MONTELUKAST REDUCES EOSINOPHILIC INFLAMMATION BY INHIBITING BOTH EPITHELIAL CELL CYTOKINE SECRETION (GM-CSF, IL-6, IL-8) AND EOSINOPHIL SURVIVAL
- 1 October 2010
- journal article
- research article
- Vol. 24 (4) , 403-411
Abstract
Leukotriene receptor antagonists, such as montelukast (MK), are currently used to treat rhinitis and asthma, but their anti-inflammatory role in eosinophil inflammation is not well understood. The aim of this study is to investigate the effect of MK on an in vitro model of upper-airway eosinophil inflammation by reducing pro-inflammatory cytokines from both nasal mucosa (NM) and polyp (NP) epithelial cells and reducing eosinophil survival primed by epithelial cell secretions. Epithelial cells were stimulated with fetal bovine serum (FBS) with/without MK for 24 hours, and cytokine concentrations in epithelial secretions were measured by ELISA. After incubating peripheral blood eosinophils with epithelial cell-conditioned media (ECM) with/without MK up to 3 days, eosinophil survival was assessed by Trypan blue dye exclusion. Results are expressed as mean +/- SEM of cytokine concentration (% of control) or eosinophil survival (%). Epithelial cell stimulation increased GM-CSF, IL-6, IL-8, and sICAM-1 secretion in both NM and NP. MK had a significant inhibitory effect on FBS-induced GM-CSF, IL-6, and IL-8 secretion, but not sICAM-1, in both NM and NP. MK also showed an inhibitory effect (p<0.05) on ECM-induced eosinophil survival from both NM (from 10(-5)M to 10(-7)M, n=7) and NP (at 10(-5)M, n=7), after 3 days of incubation. These anti-inflammatory effects on epithelial cell cytokine secretion and on eosinophil survival suggest that montelukast may contribute to the reduction of eosinophilic inflammation in upper-airway inflammatory diseases such as rhinitis and nasal polyposis.Keywords
This publication has 11 references indexed in Scilit:
- Corticosteroids and Montelukast: Effects on Airway Epithelial and Human Umbilical Vein Endothelial CellsLung, 2010
- Asthma Drugs Counter-regulate interleukin-8 Release Stimulated by Sodium Sulfite in an A549 Cell LineJournal of Asthma, 2009
- Eosinophil Progenitors in Airway DiseasesChest, 2008
- Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT1R antagonismJournal of Leukocyte Biology, 2008
- Montelukast inhibits tumour necrosis factor‐α‐mediated interleukin‐8 expression through inhibition of nuclear factor‐κB p65‐associated histone acetyltransferase activityClinical & Experimental Allergy, 2008
- BSACI guidelines for the management of rhinosinusitis and nasal polyposisClinical & Experimental Allergy, 2007
- Efficacy and safety of montelukast in adults with asthma and allergic rhinitisRespiratory Medicine, 2006
- Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trialAllergy, 2006
- The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjectsJournal of Allergy and Clinical Immunology, 2002
- Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cellsRespiratory Medicine, 2001